Clinical Trial Update: Pharmacokinetics of rFVIIIFc at Two Vial Strengths [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics study of rFVIIIFc at two vial strengths in adults with severe hemophilia A; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• rFVIIIFc (recombinant factor VIII Fc fusion protein)

Snippet

Sponsor: Bioverativ Therapeutics Inc. | Conditions: Severe Hemophilia A | Phase 1 | Status: COMPLETED | Results posted: 2016-08-19